I. Depression: Introductory Chapters1. Clinical staging in depression2. Neurodevelopmental theory of depression3. Depression after pregnancy 4. Modeling maternal depression during pregnancy: Rodent models of Major Depressive Disorder with Peripartum Onset5. Depression in mothers and mental health in children: Impact, risk factors and interventions6. Depression in college students7. Depression in disasters and traumatic events8. Depression and associated Alzheimer s disease9. Comorbidities of depression and Parkinson's disease10. Understanding the relationship between depression and alcohol among students11. Depression in obesity12. Depression and heart rate variability13. Neuroinflammation and depression14. Interlinking antidepressants and the immune system
II. Biomarkers and Diagnosis 15. Assessment scoring tools of depression16. The Beck Depression Inventory: Uses and applications17. The Hamilton Depression Rating scale: Uses and applications18. The Patient Health Questionnaire (PHQ)19. Screening for Antenatal Depression (AND) using self-report questionnaires: Conceptual issues and measurement limitations20. Edinburgh Postnatal Depression Scale: Description and applicationsJacqueline 21. The Death Depression Scale: Description and applications 22. Depression Anxiety Stress Scales: Features and Applications 23. Arabic version of the two-question Quick Inventory of Depression: Description and applications (QID-2-Ar) 24. Depressive Symptoms and Biomarkers of Cardiovascular Disease25. Thioredoxin as an antioxidant protein as a marker in depression26. Methods of neuroimaging in depression: Applications to resting-state functional connectivity 27. Neural markers of depression in MRI
III. Pharmacological Treatments for Depression28. Angiotensin receptor 1 blockade as an antidepression strategy29. Cannabinoid CB1 receptors and antidepressant effects30. Agomelatine: profiles and applications to depression31. Bumetanide and use in depressive states 32. Linking citalopram, serotonin reuptake inhibitors and depressed pregnant women 33. Citalopram and usage in sleep-deprivation-induced depression34. Monoaminergic System and Antidepressants35. Duloxetine usage in depression36. Escitalopram and blonanserin as antidepressant agents linking in neurotrophic mechanisms37. Ketamine and the role of (2R,6R)-Hydroxynorketamine in depression38. Linking 5-Hydroxytryptamine, antidepressant actions of (R)-Ketamine and social stress model 39. Mirtazapine: Multi-target strategies for treating substance use disorder and depression
IV. Counselling, Psychotherapy and Behavioural Treatments for Depression40. Mindfulness-based cognitive therapy and depression 41. Online (web based) programs for depression42. Clay art therapy on emotion regulation: Research, theoretical underpinnings, and treatment mechanisms 43. Solution-focused counselling: and use in postpartum depression44. Transcranial direct current stimulation (tDCS) combined with cognitive emotional training (CET) as a novel treatment for depression
V. Other Aspects of Treatment: Specific Groups, Monitoring and Novel Regimens45. Putative effects of cannabidiol in depression and synaptic plasticity46. Tanscutaneous vagus nerve stimulation in depression47. Exercise for depression as a primary and comorbid with obesity disorder: A narrative48. Acupressure and depression: a scientific narrative49. Potential beneficial effects of Bifidobacterium breve A1 on cognitive impairment and psychiatric disorders 50. Coenzyme Q and use in depression 51. Gene expression in Major Depressive Disorder: peripheral and brain based studies 52. Electroconvulsive therapy for depression: effectiveness, cognitive side-effects and mechanisms of action 53. Depression and offspring DNA methylation 54. Other Aspects of Treatment: Specific Groups, Monitoring and Novel Regimens: Treating depression with Theta burst stimulation (TBS)
